The aim of this study was to evaluate the hard tissue-inductive capability by human decalcified dentin matrix (DDM) with or without recombinant human bone morphogenetic protein-2 (BMP-2). Human teeth were crushed, completely decalcified and freeze-dried. We named the material DDM. The shape of DDM was a particle type and its size varied from 0.4 to 0.8 mm. The hard tissue induction by 70 mg of DDM was estimated histologically in the nude mice subcutaneous tissue at 4 weeks after implantation. The DDM alone induced bone and cartilage, independently, in the back skin. In addition, the time-course of bone induction by BMP-2 (5.0 μg)/DDM (70 mg) was analyzed in the rat subcutaneous tissues. Histological findings showed that the BMP-2/DDM induced bone and marrow between the DDM particles. Calcium content in the BMP-2/DDMinduced tissue was compatible to the histological findings. The morphometric analysis demonstrated that the BMP-2/DDM showed 66.9%, 79.0% in the volume of bone and marrow, and 32.4%, 21.0% in that of DDM at 8, 32 weeks, respectively. These results indicate that human DDM particles are osteo-chondroinductive and absorbable matrics. Human DDM are effective biomaterials of BMP-2 delivering for bone engineering.
Introduction
Bone-inductive history of dentin began in 1967 that rabbit decalcified dentin matrix (DDM) induced bone in the rabbit intramuscular pockets (Yeomans & Urist, 1967) . Several in vivo studies were published that the animal DDM induced ectopic bone formation in subcutaneous and intramuscular pockets in rodents (Huggins et al., 1970; Butler et al., 1977) .
The regeneration of lost-parts of the maxillofacial skeleton is generally carried out with autogenous bone. To obviate the need for harvesting of grafts and thus, to avoid morbidity resulting from it, the researches for bone substitutes or bone production via bio-engeneering have begun. Bone morphogenetic proteins (BMPs) were discovered from decalcified bone (Urist, 1965) .
BMPs have been investigated for its boneinducing properties (Wang et al., 1990; Wozney et al., 1988; Murata et al., 1999; Murata et al., 2001) . Therapeutic applications of recombinant human BMP-2 have carried out for regeneration and augmentation in U.S.A and E.U. Human DDM in vivo study was first reported in 1998 that the allogenic intramuscular implantation of partially decalcified dentin particles failed to induce bone formation (Ike et al., 1998) . Until now, there has been no histological evidence of ectopic bone and cartilage induction among the published papers using human DDM particles. We focused on acid-insoluble dentin as absorbable matrix and had scientific interests for its bone-inducing capability. The purposes of this study are to confirm the capacity of hard tissue induction by the particles of completely decalcified dentin and to estimate the efficacy of human DDM as carrier matrix for the BMP-2 delivery.
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Materials and Methods

Preparations of human DDM
Teeth were donated by out-patients at Health Sciences University of Hokkaido. The extracted third molar teeth were collected and prepared for completely decalcified dentin matrix (DDM). Briefly, the teeth were crushed in liquid nitrogen, washed in 1 M sodium chloride, and decalcified completely in 0.6 N HCl solution (pH2.0) for DDM. The DDM particles were extensively rinsed in cold distilled water and lyophilized. The particle sizes varied from 0.4 to 0.8 mm (Fig. 1) .
Bacteriological examination
DDM granules were cultured at 36.5 for 7 days in thioglycollate medium (BBLTM, BD JAPAN).
Human DDM alone implant
Nude mice (male, 4 week-old) were subjected to intraperitoneal anesthesia with pentobarbital sodium (4 mg/100 g body weight). Two subcutaneous pockets were prepared in the back skin. After implantation, the incisions were sutured with nylon threads. The implanted materials were removed at 4 weeks.
Composition of BMP-2 solution and DDM
One hundred micro-liter of recombinant human BMP-2 (50 μg/ml PBS) solution was mixed with 70 mg of DDM in a cutopened tuberculine syringe.
BMP-2/DDM implant
Operations in Wistar rats (male, 4 week-old) were done 
